Publication details
Srdeční frekvence: klinický ukazatel a marker rizika
| Title in English | Heart Rate: Clinical Variable and Risk Indicator |
|---|---|
| Authors | |
| Year of publication | 2014 |
| Type | Article in Periodical |
| Magazine / Source | Medicína po promoci |
| MU Faculty or unit | |
| Citation | |
| Field | Cardiovascular diseases incl. cardiosurgery |
| Keywords | chronic heart failure; beta-blockers; ivabradine; cardiovascular prognosis; heart rate |
| Description | Resting heart rate (HR) is a significant risk factor of cardiovascular mortality and morbidity in patients with chronic heart failure. Pharmacological slowing of the HR significantly improves prognosis in these patients. New heart rate slowing drug, ivabradine, either in combination with a beta-blocker or as monotherapy if the beta-blocker is contraindicated. Additional HR slowing leads to further prognostic improvement. |